May Bacterial Infections Trigger Bullous Pemphigoid? Case Report and Review of Literature
- PMID: 34200214
- PMCID: PMC8229970
- DOI: 10.3390/microorganisms9061235
May Bacterial Infections Trigger Bullous Pemphigoid? Case Report and Review of Literature
Abstract
Bullous pemphigoid (BP) is an autoimmune blistering skin disease, mainly observed in the elderly. Infections have been suggested as possible disease triggers. However, infections may even heavily influence the disease clinical course and mortality. A 75-year-old woman was admitted to hospital for severe erythematosus blistering disease, accompanied by hyper-eosinophilia and hyper-IgE. The culture of bullous fluid was positive for Enterococcus faecalis, the blood culture was positive for Staphylococcus aureus, and the urine culture was positive for Proteus mirabilis and Escherichia coli. Moreover, circulating anti-BP180 IgG was present and the histopathological/ultrastructural examination of a lesional skin biopsy was compatible with BP. High eosinophil levels (up to 3170/µL) were found throughout the clinical course, while values below 1000/µL were associated with clinical improvement. The total IgE was 1273 IU/mL, and specific anti-G/V-penicillin/ampicillin IgE antibodies were positive. The patient had a complete clinical recovery in two months with methyl-prednisolone (40 then 20 mg/day) and low-dose azathioprine (50 mg/day) as a steroid-sparing agent. The steroid treatment was tapered until interruption during a one-year period and intravenous immunoglobulins have been administered for three years in order for azathioprine to also be interrupted. The patient stopped any treatment five years ago and, in this period, has always been in good health. In this case, the contemporaneous onset of different bacterial infections and BP is suggestive of bacterial infections acting as BP trigger(s), with allergic and autoimmune pathways contributing to the disease pathogenesis.
Keywords: IVIg; autoimmunity; bullous pemphigoid (BP); infections.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Bullous Pemphigoid Masquerading as Erythema Annulare Centrifugum.Acta Dermatovenerol Croat. 2017 Oct;25(3):255-256. Acta Dermatovenerol Croat. 2017. PMID: 29252183
-
Levels of anti-BP180 NC16A IgE do not correlate with severity of disease in the early stages of bullous pemphigoid.Arch Dermatol Res. 2015 Nov;307(9):849-54. doi: 10.1007/s00403-015-1598-3. Epub 2015 Sep 24. Arch Dermatol Res. 2015. PMID: 26404084
-
Correlation of Serum Levels of IgE Autoantibodies Against BP180 With Bullous Pemphigoid Disease Activity.JAMA Dermatol. 2017 Jan 1;153(1):30-38. doi: 10.1001/jamadermatol.2016.3357. JAMA Dermatol. 2017. PMID: 27829102
-
Successful treatment of bullous pemphigoid with omalizumab as corticosteroid-sparing agent: report of two cases and review of literature.J Eur Acad Dermatol Venereol. 2016 Oct;30(10):1778-1782. doi: 10.1111/jdv.13758. Epub 2016 Jun 29. J Eur Acad Dermatol Venereol. 2016. PMID: 27357866 Review.
-
The Intersection of IgE Autoantibodies and Eosinophilia in the Pathogenesis of Bullous Pemphigoid.Front Immunol. 2019 Oct 4;10:2331. doi: 10.3389/fimmu.2019.02331. eCollection 2019. Front Immunol. 2019. PMID: 31636640 Free PMC article. Review.
Cited by
-
C-Reactive Protein: Pathophysiology, Diagnosis, False Test Results and a Novel Diagnostic Algorithm for Clinicians.Diseases. 2023 Sep 28;11(4):132. doi: 10.3390/diseases11040132. Diseases. 2023. PMID: 37873776 Free PMC article. Review.
-
Blisters and Milia around the Peritoneal Dialysis Catheter: A Case of Localized Bullous Pemphigoid.Dermatopathology (Basel). 2022 Aug 4;9(3):282-286. doi: 10.3390/dermatopathology9030033. Dermatopathology (Basel). 2022. PMID: 35997350 Free PMC article.
-
Editorial for Special Issue: Microbial and Autoimmune Disease.Microorganisms. 2021 Aug 24;9(9):1800. doi: 10.3390/microorganisms9091800. Microorganisms. 2021. PMID: 34576696 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources